Rafael Fonseca, MD from the Mayo Clinic, Scottsdale, AZ talks about the new therapies in multiple myeloma, such as ixazomib, elotuzumab, daratumumab and Isatuximab.
Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting, in Orlando, FL.
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content